 M. Results from embryo-fetal development indicated that satraplatin should be considered a teratogen in women of childbearing potential and hazardous in respect to spermatogenesis for men. For this reason, men must agree to use adequate contraception abstinence; hormonal or barrier method of birth control prior to study entry and for the duration of study participation. 